Daily dividend news for investors in dividend stocks

Abbott Laboratories: A Dividend Aristocrat on Sale

Published Tue, 22 Jun 2010 17:19:36 -0400 on Seeking Alpha

Very few companies can match the consistent operating record of Abbott Laboratories (ABT). For more than 120 years, Abbott has demonstrated a durable and sustainable record as a growth company. As a broad-based healthcare company their diversified business strategy has enabled them to consistently generate top-tier performance versus their peers.For calendar 2009, Abbott was once again named to the Standard & Poor's 500 Dividend Aristocrats Index, a feat only 10% of S&P 500 companies have achieved. In February of 2010 Abbott increased their dividend by 11%. This marked the 37th consecutive year of rising dividends, and the 344th consecutive quarterly dividend. On June 11, 2010 they announced another dividend of $0.44, marking the 38th year of increase and the 346 consecutive dividend since 1924. Abbott's current dividend yield is 3.6%.... Read more

Stock name Last trade   P/E Earnings/Share Dividend/Share Dividend yield
ABBOTT LABORATORIES 85.21   52.3 1.63 1.28 1.54


Older articles featuring Abbott Laboratories (ABT):
November Buys: 3 Monthly Paying CEFs, Plus Some Dividend Growth Opportunities
Dividend Challenger Highlights: Week Of December 13
My Dividend Growth Portfolio November Review: 32 Holdings, 1 Buy
Dividend Challenger Highlights: Week Of November 8
My Dividend Growth Portfolio - Q3 2020 Summary
Dividend Challenger Highlights: Week Of October 11
The Dividend Growth 30 Deliver
My Dividend Growth Portfolio Q3 Review: 34 Holdings, 4 Sales, 3 Buys
Dividend Aristocrats In The Defensive Sectors
Dividend Income Update: August 2020